Delivery Order SPE2DB22D2009-SPE2DB25FL8EE
Award Date
3/6/25
Potential Completion Date
3/7/25
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML vaccine to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp. The $1,400.76 firm fixed-price delivery order contract has a completion date of December 11, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML vaccine made by Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,431.94 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product, to the Defense Logistics Agency (DLA). The $10,511.40 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 25, 2025 and was awarded on February 24, 2025. There was no set-aside designation for this award. AmerisourceBergen holds a $999,999,999...
This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,342.60 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of May 3, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products to the Defense Logistics Agency (DLA). The $9,129.99 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 12, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,648.91 firm fixed-price delivery order covers the supply of the ENGERIX-B 20 MCG/ML SYRNML vaccine. The contract has an ultimate completion date of April 3, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.57 firm fixed-price delivery order is for the supply of 4566661219 ENGERIX-B 20 MCG/ML SYRNML, with a completion date of December 10, 2024. This contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,016.55 firm fixed-price delivery order is for ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,716.65 Firm Fixed Price Delivery Order contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has an ultimate completion date of December 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,016.22 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive...